The Second Helping of Doubt: Talking CBD With Parents and Grandparents at the Family Table

Family meals have a way of producing unexpected conversations. One week it is a neighbour’s new shed; the next it is a bottle of CBD oil glimpsed on a kitchen counter. For many UK households, the question is not whether CBD will come up, but how to discuss it without exaggerating benefits, dismissing concerns or making an older relative feel sold to.

The sensible starting point is simple: curiosity deserves a calm answer, not a campaign. Parents and grandparents may have heard CBD described as a cure-all, a legal high, a modern snake oil or a harmless food supplement. None of those descriptions is adequate. A better conversation begins with what CBD is, what the evidence can and cannot support, and why medicine checks matter more than marketing language.

Listen Before You Label

Older relatives often bring a specific concern to the table: poor sleep, joint discomfort, anxiety before appointments, or a general wish to feel less stiff in the morning. It is tempting to respond with a product recommendation. Resist that reflex. Ask what prompted the interest, what they have already tried, and whether they have discussed the issue with their GP.

This is not deflection. It is triage. CBD is not a treatment for every symptom, and over-the-counter CBD products in the UK are sold as food supplements rather than licensed medicines. They should not be presented as a substitute for prescribed care. If a relative is struggling with persistent pain, low mood, sleep problems or anxiety, the first conversation should be with a healthcare professional, not with a retailer’s chat window.

What the Evidence Can Realistically Carry

The evidence base for CBD is uneven. There is licensed medicinal CBD for specific rare epilepsy syndromes, and there is a separate prescription system for unlicensed medicinal cannabis products in the UK. Those are clinical pathways, not high-street shopping categories. For everyday wellness products, the evidence is much thinner and often preliminary.

That does not mean CBD is worthless. It means the honest position is modest. Some people report feeling calmer or sleeping better; others notice little. Studies vary in quality, dose and population, and many consumer products have not been tested in the way medicines are. A family conversation should reflect that uncertainty rather than resolve it with confidence nobody can justify.

A useful sentence is: “The evidence is interesting but not settled, and it is not a replacement for your prescribed treatment.” That is less exciting than a miracle story, but it is more respectful.

The Polypharmacy Point

Older adults are more likely to take several medicines, and that changes the CBD conversation. Polypharmacy — the use of multiple medicines — raises the chance of interactions. CBD can affect how some drugs are metabolised in the body, and it may add to effects such as drowsiness or changes in blood pressure. The precise risk depends on the medicines, the dose and the person.

This is why a GP or pharmacist check is not bureaucratic fuss. It is the responsible step before anyone adds a new product to an existing routine. A high-street pharmacist can review a medicine list and discuss potential interactions; a GP can consider symptoms in context. If a relative is taking blood thinners, epilepsy medicines, immunosuppressants, blood pressure medication or sedatives, that conversation becomes more important, not less.

Practical advice helps. Suggest writing down the exact product name, CBD content per dose, batch number and frequency, then taking that note to the pharmacist. “I am thinking of trying this” is a far better opening than “I have been taking this for a month.”

Labels, Law and the British Shelf

In the UK, CBD products sold as food supplements must comply with novel food requirements, and reputable retailers should be able to explain their position on the Food Standards Agency’s novel food register. Labels should state CBD content clearly, avoid medicinal claims and not imply the product can diagnose, treat or cure illness. THC content should be within legal limits, and independent laboratory certificates should be available.

These are consumer rights issues as much as labelling preferences. If an older relative is considering a purchase, help them read the back of the bottle rather than the front. Look for a clear milligram figure per dose, a batch code, storage instructions and a retailer with a UK address and a returns policy. Be wary of anything sold with grand claims, urgent countdown timers or pressure to buy several bottles at once.

Keep the Meal Out of the Sales Funnel

The most common family mistake is turning concern into conversion. An older relative mentions a bad knee; someone produces a bottle from their bag; the conversation becomes a demonstration. That may feel helpful, but it can also feel coercive. Older people are often polite, and politeness is not consent.

A better approach is to offer information without an agenda. Share a neutral article. Suggest a pharmacist conversation. Offer to help check a label. Do not push a product you happen to like, and do not imply that scepticism is ignorance. If they decide CBD is not for them, let that be a satisfactory outcome.

A Short Script That Usually Works

“There is some evidence worth watching, but it is not a cure and it can interact with medicines. If you are curious, the sensible next step is to ask your pharmacist or GP, especially because of the other tablets you take. I can help you write down the product details if that would be useful.”

That covers evidence, safety and autonomy without a sales pitch. It also leaves room for the relative to lead.

When to Stop Talking

If the conversation becomes heated, repetitive or pressured, stop. Family meals are not clinics. A relative who feels cornered will not absorb safety information, and a younger family member who feels responsible for a parent’s health may overstate certainty. Agree to revisit the subject another time, preferably with the medicine list and a pharmacist’s advice to hand.

CBD may deserve a place in some people’s wellness routines, but it does not deserve a place at the centre of every family gathering. The calmer aim is to replace hype with useful questions: What is the evidence? What else is being taken? Who has reviewed the medicine list? What does the label actually say? Those questions do not spoil Sunday lunch. They make it more honest.